SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-021282
Filing Date
2020-10-19
Accepted
2020-10-19 16:15:10
Documents
6
Period of Report
2020-10-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20201015_8k.htm 8-K 55923
2 EXHIBIT 2.1 ex_207097.htm EX-2.1 682050
3 EXHIBIT 10.1 ex_207098.htm EX-10.1 64608
4 EXHIBIT 99.1 ex_207399.htm EX-99.1 28981
5 cytocom.jpg GRAPHIC 4987
6 logo.jpg GRAPHIC 4836
  Complete submission text file 0001437749-20-021282.txt   846439
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 201246336
SIC: 8731 Services-Commercial Physical & Biological Research